1. Division of Immunotherapy, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
2. Newcastle General Hospital, Newcastle Upon Tyne, UK.
3. Service de Médecine Interne et Pathologie Vasculaire, Inserm U976, Hôpital Saint-Louis, 75010 Paris, France.
4. Hematology Department, Bone Marrow Transplantation Unit, Cell and Gene Therapy Center, George Papanicolaou Hospital, 57010 Exokhi, Thessaloniki, Greece.
5. Charité University Medicine Berlin, Department of Rheumatology and Clinical Immunology and German Rheumatism Research Centre Berlin, A Leibniz Institute, Charitépaltz 1, D-10117 Berlin, Germany.
6. MS Center, Department of Neurology, First Medical Faculty, Charles University in Prague, Katerinská 30, 128 08, Prague, Czech Republic.
7. Department of Pathology, Regeneration Research Center for Intractable Diseases, Center for Cancer Therapy, Kansai Medical University, 10–15 Fumizono-cho, Moriguchi City, Osaka 570-8506, Japan.
8. Department of Haematology, HSCT Program, Singapore General Hospital, 169608 Singapore.
9. Division of Hematology and Stem Cell Transplantation, Azienda-Ospedaliera Universitaria San Martino, Genoa, Italy.
10. University of São Paulo (USP), Hemocentro Regional e Unidade de Transplante de Medula Óssea–HCF-MRP-USP, Rua Tenente Catão Roxo, 2501, CEP 14051-140, Ribierao, Preto, São Paulo, Brazil.
11. Sheffield Teaching Hospitals NHS Trust, University of Sheffield, UK.
12. The International Center for Cell Therapy and Cancer Immunotherapy (CTCI), Weizman Center, Tel Aviv, Israel.